Probiotic Label Accuracy, Contamination and Third-Party Testing
What independent lab analyses found when they checked probiotic labels for strain names, live counts and contaminants, and how third-party testing fits in.
Content last updated . This page has not been medically reviewed.
Quick answer
Several independent laboratory studies have compared what probiotic products say with what they contain. Results vary by study and by product: some found labels mostly accurate, others found a meaningful share with lower live counts or wrong or missing species. The studies are small snapshots of products sold at one time, so they cannot rank or describe any particular product. Information only; this page names no brands.
Evidence labels used here: mixed, insufficient evidence, and Proper evidence not found.
Why the label matters
In the US, many probiotics are sold as dietary supplements, which do not require FDA approval before they are marketed. [1] The NHS notes that probiotics are generally classed as food rather than medicine, so they do not go through the testing medicines do, and we cannot always be sure the product actually contains the bacteria stated on the label. [2]What independent analyses found
| Study | Products and method | Findings | Label |
|---|---|---|---|
| Patro and colleagues, 2016 (mSphere) | Popular US probiotic products; whole-genome sequencing, PCR and colony counts | Products adhered to ingredient claims overall and lot-to-lot differences were minimal; a few discrepancies in naming of closely related species; one product had an apparent Enterococcus contaminant in two of its three lots; only one was inaccurate in viability. [3] | Mixed |
| Morovic and colleagues, 2016 (Frontiers in Microbiology) | 52 commercial supplements; plate counts and genotyping | 17 samples (33%) were below label claim for CFU before their expiration dates; only 30 of 52 (58%) had a correctly labeled classification. [4] | Mixed |
| Study of 17 products sold in mainland China, 2019 (Microorganisms) | Selective culturing plus sequencing | Five products (29.41%) had inaccurate or lower CFU counts on culture media, and four (23.52%) had inaccurately labeled classification; no contaminant was identified. [5] | Mixed |
| Pilot study of 17 infant probiotic products, 2025 (Pediatric Research) | 16S sequencing, fungal DNA tests, culture | Over 82% of bacterial DNA matched species on labels; contaminating bacteria were closely related species; fungal DNA found in some samples was not viable. [6] | Mixed |
Reading across them:
- Identity. Problems reported included wrong, missing or unlisted species, with discrepancies in the naming of closely related species. [3][6]
- Live counts. In the 52-product study, products labeled with counts at time of manufacture had significantly lower average CFU than those labeled "to expiration," which is why a label's wording on when the count applies matters. [4]
- Contamination. One apparent Enterococcus contaminant and some non-viable fungal DNA were reported in the studies above; the China study found none. [3][6][5]
- Blends. Multi-strain products varied more from their labels than single-strain ones in the infant pilot. [6] See multi-strain products and blends.
- Limits. The studies tested different products in different countries and years, using different methods. The authors of the infant study say their results call for better standardization and quality control. [6] None of them show that an accurate label means a product works.
Third-party testing
Third-party testing means an independent laboratory, not the maker, checks a product, for example for strain identity, live count and contaminants. The methods used in the studies above (culture counts, genotyping, sequencing) show what such testing can look for. Morovic and colleagues, for instance, assessed strain identity with methods published by the United States Pharmacopeial Convention. [4] We did not read the rules of any certification program for this page, so we do not describe what any program checks for probiotics. For how testing marks are described in general, see quality testing and certifications. A testing mark cannot tell you whether the strain has evidence for your goal.Safety
Contamination and wrong labels matter most for people with weakened immune systems, central lines or serious illness, and for premature infants; the FDA warns premature infants given probiotic products are at risk of invasive, potentially fatal infection. [7] The NCCIH advises consulting a health care provider before a probiotic supplement, especially with health problems. [1] Report a bad reaction to a clinician. For label basics see how to read a probiotic label.Frequently asked questions
Are probiotic labels accurate?
Studies disagree. One US study found products mostly matched ingredient claims, while another found 33% below label claim for CFU before expiry and only 58% correctly classified. [3][4]
Do probiotics contain what the label says?
Often, but not always. A pilot of 17 infant products found over 82% of bacterial DNA matched labeled species. [6]
Can probiotic products be contaminated?
Contamination was reported in some studies, such as an apparent Enterococcus contaminant in one product, while another study found none. [3][5]
Does third-party testing guarantee a probiotic works?
Proper evidence not found. We read no source showing that testing marks predict benefit; testing addresses identity, count or contaminants, not whether the strain helps.
Is the FDA checking probiotic labels before sale?
For dietary supplements, the NCCIH says FDA approval is not required before marketing. [1]
References
- National Center for Complementary and Integrative Health (US). Probiotics: Usefulness and Safety. Read 2026-10-22.
- NHS (UK). Probiotics. Page last reviewed 24 November 2022. Read 2026-10-22.
- Patro JN, et al. Culture-Independent Metagenomic Surveillance of Commercially Available Probiotics with High-Throughput Next-Generation Sequencing. mSphere 2016. Read 2026-10-22.
- Morovic W, et al. Genotyping by PCR and High-Throughput Sequencing of Commercial Probiotic Products Reveals Composition Biases. Front Microbiol 2016. Read 2026-10-22.
- Viability and Composition Validation of Commercial Probiotic Products by Selective Culturing Combined with Next-Generation Sequencing. Microorganisms 2019. Read 2026-10-22.
- Genomic interrogation of commercial infant probiotic products for label accuracy. Pediatr Res 2025. Read 2026-10-22.
- US Food and Drug Administration. FDA raises concerns about probiotic products sold for use in hospitalized preterm infants (October 2023). Read 2026-10-22.
Education, not medical advice. This page is for general information. It does not diagnose or treat any condition and is not a substitute for care from a qualified health professional. Natural does not automatically mean safe. Ask a clinician or pharmacist before changing your care, especially if you take medication, are pregnant or breastfeeding, or have a health condition.